Using quantitative immunohistochemistry to TH and DAT, PD brains, relative to controls, showed 35–75% loss of dopamine terminals in the putamen at years 1–3 after diagnosis, and 70–90% loss by year 5 after diagnosis relative to controls. The gene discussed is SLC6A3; the disease is Parkinson disease.